In triple-negative breast cancer, high expression of XPO1 accelerates proliferation by exporting oncogene mRNAs such as MYC and ERBB2, inhibits mitochondrial release of Cyt c, and weakens apoptotic sensitivity (Zhao et al., 2021). This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.